Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat domain phosphoinositide-interacting protein 3, pseudogene (ENSG00000267404) is classified as a pseudogene related to the protein-coding gene WDR45B (also known as WIPI3), a member of the WD40 repeat–containing protein family involved in autophagy in its functional form. This pseudogene does not encode a functional protein and, therefore, has no known biological function or relevance as a therapeutic target. The protein-coding version, WDR45B, encodes a component of the autophagy machinery, but the pseudogene itself is not implicated in disease or drug targeting[4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain phosphoinositide-interacting protein 3, pseudogene (WDR45B, pseudogene).